Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ALLO-316 |
Trade Name | |
Synonyms | ALLO 316|ALLO316 |
Drug Descriptions |
ALLO-316 consists of allogeneic T-cells expressing a CD70-targeting chimeric antigen receptor (CAR), which potentially results in increased killing of tumor cells expressing CD70 and reduced tumor growth (Blood (2020) 136 (Supplement 1): 23). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C177917 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ALLO-316 | ALLO-316 | 0 | 1 |